Holdings
T. Rowe Price Health Care ETF
As of Jun 30, 2026, T. Rowe Price Health Care ETF reported 93 positions worth US$22.5M. Largest: Eli Lilly And Company, Unitedhealth Group Incorporated and Gilead Sciences, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Eli Lilly And Company | 3,209 | US$3.85M | +20 | Jun 30, 2026 |
| Unitedhealth Group Incorporated | 3,614 | US$1.5M | −1,284 | Jun 30, 2026 |
| Gilead Sciences, Inc. | 8,084 | US$1.02M | +2,064 | Jun 30, 2026 |
| Thermo Fisher Scientific Inc | 1,890 | US$948K | −3 | Jun 30, 2026 |
| Danaher Corporation | 3,580 | US$682K | +662 | Jun 30, 2026 |
| Cencora, Inc. | 2,240 | US$634K | +1,555 | Jun 30, 2026 |
| Agilent Technologies, Inc. | 4,530 | US$602K | +1,534 | Jun 30, 2026 |
| Alnylam Pharmaceuticals, Inc. | 1,986 | US$598K | +724 | Jun 30, 2026 |
| Intuitive Surgical, Inc. | 1,410 | US$561K | +1,276 | Jun 30, 2026 |
| Insulet Corporation | 3,601 | US$548K | +2,798 | Jun 30, 2026 |